Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

January 21, 2022

A Missed Case of Area Postrema Syndrome Presenting with Neuromyelitis Optica Spectrum Disorder.

The American Journal of Case Reports
Faisal KhanMunmun Aziz
January 21, 2022

Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Giuseppe LiberatoreEduardo Nobile-Orazio
January 21, 2022

An in-silico analysis to identify structural, functional and regulatory role of SNPs in hMRE11.

Journal of Biomolecular Structure & Dynamics
Bhoomi Tarapara, Franky Shah
January 21, 2022

Reply to: "Microvascular Breakdown Due to Retinal Neurodegeneration in Ataxias".

Movement Disorders : Official Journal of the Movement Disorder Society
Fernando Spina TensiniHélio Afonso Ghizoni Teive
January 21, 2022

Magnetic Resonance Imaging-Guided Focused Ultrasound Thalamotomy in Spinocerebellar Ataxia Type 12.

Movement Disorders : Official Journal of the Movement Disorder Society
Veronika PurrerValeri Borger
January 20, 2022
Open Access

Linking Dynamic DNA Secondary Structures to Genome Instability

BioRxiv : the Preprint Server for Biology
Andre nussenzweigS. M. Mirkin
January 20, 2022

Impaired oligodendrocyte maturation is an early feature in SCA3 disease pathogenesis.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Kristen H SchusterHayley S McLoughlin
January 20, 2022

Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2.

Proceedings of the National Academy of Sciences of the United States of America
Radhakrishnan KanagarajStephen C West
January 20, 2022
Open Access

Phenotypic heterogeneity in patients with NEFL-related Charcot-Marie-Tooth disease.

Molecular Genetics & Genomic Medicine
Hye Jin KimByung-Ok Choi
January 19, 2022

Cryo-EM Structure of AMP-PNP-bound Human Mitochondrial ATP-binding cassette transporter ABCB7.

Journal of Structural Biology
Qinqin YanXue Yang
January 19, 2022

[Diversity of CACNA1A-related disorders].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
G E RudenskayaO A Shchagina
January 19, 2022

[Spinocerebellar ataxia 17: full phenotype in a 42 CAG/CAA-repeats carrier].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
D V IS N Illarioshkin
January 19, 2022

The Cerebellum in Niemann-Pick C1 Disease: Mouse Versus Man.

The Cerebellum
Maria Teresa FiorenzaRobert P Erickson
January 18, 2022

How to Detect Isolated PEX10-Related Cerebellar Ataxia?

Esmeralda NavaEugen Boltshauser
January 17, 2022

Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.

Cellular and Molecular Life Sciences : CMLS
Marta Medina-CarboneroJordi Tamarit

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved